Direct lineage conversion offers a new strategy for tissue regeneration and disease modelling. Despite recent success in directly reprogramming fibroblasts into various cell types, the precise changes that occur as fibroblasts progressively convert to the target cell fates remain unclear. The inherent heterogeneity and asynchronous nature of the reprogramming process renders it difficult to study this process using bulk genomic techniques. Here we used single-cell RNA sequencing to overcome this limitation and analysed global transcriptome changes at early stages during the reprogramming of mouse fibroblasts into induced cardiomyocytes (iCMs) 1-4 . Using unsupervised dimensionality reduction and clustering algorithms, we identified molecularly distinct subpopulations of cells during reprogramming. We also constructed routes of iCM formation, and delineated the relationship between cell proliferation and iCM induction. Further analysis of global gene expression changes during reprogramming revealed unexpected downregulation of factors involved in mRNA processing and splicing. Detailed functional analysis of the top candidate splicing factor, Ptbp1, revealed that it is a critical barrier for the acquisition of cardiomyocyte-specific splicing patterns in fibroblasts. Concomitantly, Ptbp1 depletion promoted cardiac transcriptome acquisition and increased iCM reprogramming efficiency.
contain a wide spectrum of cells that are transitioning from fibroblast to iCM. We therefore performed single-cell RNA sequencing (RNA-seq) on day-3 cardiac fibroblasts infected with separate Mef2c, Gata4 and Tbx5 viral constructs (hereafter M + G + T) from seven independent experiments (for experimental design, see Extended Data Fig. 1 ), followed by a series of quality control steps (Extended Data Fig. 1 , Methods and Supplementary Tables 1, 2). Extensive data normalization was performed to correct for technical variations and batch effects (Extended Data Figs 1, 2 and Methods). After comparing the entire set of single-cell RNA-seq data to bulk RNA-seq data of endogenous cardiac fibroblasts and cardiomyocytes that were obtained from parallel experiments, we detected a group of resident or circulating immune or immune-like cells (Extended Data Fig. 3 ) that were not included in the subsequent analyses.
Unsupervised hierarchical clustering and principal component analysis (PCA) on the remaining 454 non-immune cells revealed three gene clusters that account for most of the variability in the data: cardiomyocyte-, fibroblast-and cell-cycle-related genes (Fig. 1a, b and Extended Data Fig. 4a-c) . On the basis of the expression of cell-cyclerelated genes, the cells were grouped into cell-cycle-active (CCA) and cell-cycle-inactive (CCI) populations (Fig. 1a) ; this was confirmed by the molecular signature of the cells in their proliferation states (Extended Data Fig. 4d -g, proliferating or non-proliferating). Within CCA and CCI populations, hierarchical clustering further identified four subpopulations based on differential expression of fibroblast versus cardiomyocyte genes: fibroblasts, intermediate fibroblasts, pre-iCMs and iCMs ( Fig. 1a ). When plotted using PCA or t-distributed stochastic neighbour embedding analysis, a stepwise transcriptome shift from fibroblast to intermediate fibroblast to pre-iCM to iCM was evident ( Fig. 1c and Extended Data Fig. 4h , i). We also analysed the reprogramming process as a continuous transition using SLICER (selective locally linear inference of cellular expression relationships) 17 , an algorithm for inferring nonlinear cellular trajectories ( Fig. 1d, e ). The trajectory built by SLICER suggested that fibroblasts, intermediate fibroblasts, pre-iCMs and iCMs form a continuum on the bottom CCI path, representing an iCM-reprogramming route. We further calculated the pseudotime for each cell on the trajectory by defining a starting fibroblast and measuring the distance of each single cell to the starting cell along the reprogramming route ( Fig. 1e ). We then examined the distribution of cells along the pseudotime line by plotting the 'free energy' (max(density) − density) of the trajectory and discovered a peak (lowest density) in pre-iCM state (Fig. 1f ). These data suggest that the pre-iCM stage is an unstable cell state seeking to settle into a more stable state, such as the iCM state, consistent with the PCA and hierarchical clustering analysis showing that pre-iCMs express both cardiomyocyte and fibroblast markers as an intermediate cell type and our other experimental evidence (Fig. 1a-c and Extended Data Fig. 4j-o) . To experimentally test the iCM route, we performed population-based gene expression profiling at reprogramming days 0, 3, 5, 7, 10 and 14 (Fig. 1g , h and Extended Data Fig. 4p -v). PCA generated a pattern showing an oriented path during reprogramming ( Fig. 1g and Extended Data Fig. 4p-s) . Expression of the three main gene clusters selected from single-cell data showed consistent changes in population data ( Fig. 1h and Extended Data Fig. 4t -v), supporting the SLICER trajectory.
By analysing CCA and CCI populations, we found that even though proliferative iCMs (CCA iCMs) were observed ( Fig. 1a-d) , iCMs and pre-iCMs were predominantly CCI ( Fig. 1i ). We therefore designed four sets of experiments to address the relationship between cell proliferation and iCM reprogramming by: (1) manipulating the expression of cell-cycle-related genes in fibroblasts that were lentivirally transduced with M + G + T (Extended Data Fig. 5a We next examined the cellular composition of our isolated starting cardiac fibroblasts (see Methods) and identified five subpopulations ( Fig. 2a, b , Extended Data Fig. 6a -i and Supplementary Discussion 1). To delineate how these subpopulations were reprogrammed, we applied hierarchical clustering calculated from the starting cardiac fibroblasts to those that had been transduced with M + G + T and determined the correlation of the expression of non-cardiomyocyte lineage markers to the status of reprogramming (Fig. 2c ). Expression of both endothelial and epicardial genes was significantly decreased in all cells that were transduced with M + G + T, irrespective of the reprogramming status. However, fibroblast and myofibroblast and/or smooth muscle genes were suppressed in iCMs, but not in intermediate fibroblasts or pre-iCMs ( Fig. 2c and Extended Data Fig. 6j , k); this finding was supported by experimental data tracking protein expression of representative markers along the reprogramming trajectory ( Fig. 2d-f and Extended Data Fig. 6l, m) . Therefore, we conclude that endothelial and epicardial genes can be readily suppressed, whereas fibroblast and myofibroblast and/or smooth muscle genes were gradually suppressed along the course of reprogramming. This differential suppression is consistent with the difference in the layer of origin among different cardiac cell lineages during development and suggests that recent (epigenetic) memories might be easier to be erased than ones that have been gained earlier in development. The progressive suppression 
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of fibroblast markers also indicates that there is a difference between iCM and induced pluripotent stem cell (iPS cell) reprogramming, because early downregulation of fibroblast markers, such as Thy1, is one of the hallmarks and prerequisites for iPS cell reprogramming to proceed 18 .
To understand the molecular cascades that underlie iCM induction, we performed nonparametric regression and k-medoid clustering (see Methods), and identified three major clusters of genes that are significantly related to and show similar trends during reprogramming (Extended Data Fig. 7a-d ). Further analysis identified six smaller gene clusters with narrower variation across the trend and gene ontology analyses were performed for each cluster ( Fig. 3a -g, Supplementary  Table 3 and Supplementary Discussion 2). The largest cluster (cluster 1) that shows a trend of immediate and continuous downregulation of gene expression is enriched in gene ontology terms related to protein translation/biosynthesis, modification and transportation ( Fig. 3b ). Such changes are probably to balance for increased energy requirements during the cell-fate switch and/or to transit from a protein production and 'secretion factory' (a fibroblast) to an energy-consuming 'power station' (a cardiomyocyte). The downregulated genes in cluster 2 are enriched in gene ontology terms that suggest a late suppression of fibroblast genes and growth factors, whereas the upregulated genes in clusters 4 and 5 are enriched in gene ontology terms that indicate engagement in a metabolic shift and structural changes towards a cardiomyocyte fate ( Fig. 3e, f) .
Unexpectedly, we found that cluster 1 is also enriched in the gene ontology terms 'mRNA splicing' , 'mRNA processing' and 'RNA recognition motif ' . This finding prompted us to interrogate the role of splicing factor(s) in iCM induction. We therefore used an inducible iCM cell line derived from mouse embryonic fibroblasts (icMEFs) 19 to screen a short hairpin RNA (shRNA) library that targeted 26 splicing factors representing the most common splicing factor families 20 and identified Ptbp1 as the top candidate that also showed differential expression in cardiac fibroblasts versus cardiomyocytes (Extended Data Fig. 7e-h) . Notably, knockdown of Ptbp1 in various primary fibroblasts consistently resulted in a significant increase in reprogramming efficiency ( Fig. 3h , i and Extended Data Fig. 8a -p), demonstrating that Ptbp1 is a general barrier to iCM induction. However, overexpression of Ptbp1 has minimal effects (Extended Data Fig. 8q -u). To understand how Ptbp1 silencing led to improved iCM reprogramming, we performed high-depth RNA-seq to analyse alternative splicing events of day-3 reprogramming cells with or without Ptbp1 expression. A total of 1,494 alternative splicing events were detected upon Ptbp1 knockdown, 97% of which were not induced by MGT alone (Extended Data Fig. 9a and Supplementary Tables 4, 5) . Notably, calculation of the difference in the percentage of spliced-in (Δ PSI) suggested that alternative splicing events between reprogramming versus control fibroblasts and endogenous cardiomyocytes versus cardiac fibroblasts were in an opposite direction (negative association, P = 0.008). Knockdown of Ptbp1 in reprogramming fibroblasts, however, induced a strong positive association (P = 2.2 × 10 −16 ), suggesting that Ptbp1 silencing together with MGT, but not MGT alone, shifted the splicing pattern from cardiac fibroblast towards cardiomyocyte ( Fig. 3j, k ). Furthermore, a higher percentage of exon-skipping events (63%) of the five known alternative splicing types was observed in MGT-infected cells upon Ptbp1 silencing ( Fig. 3l ). Motif analysis using the RNA map analysis and plotting server (rMAPS) 21 showed that a CT-rich Ptbp1-binding motif was significantly enriched in exon-skipping exons compared to background exons (Fig. 3m ). Notably, in exons that were included more often upon Ptbp1 knockdown, the motif was strongly enriched within 100 bp of the upstream intron (P < 1 × −30 ), whereas, in exons that were skipped more often upon Ptbp1 knockdown, the motif was less strongly enriched, but showed a broad peak at 50-200 bp in the downstream intron (P < 0.05). These data are consistent with the higher percentage of inclusion (69%) than skipping (31%) among exon-skipping events that were observed in Ptbp1 knockdown samples (Extended Data Fig. 9b ), suggesting that Ptbp1 is a repressor of exon inclusion when bound to an upstream intron, and probably is a weaker repressor of exon skipping when bound to a downstream intron. Next we assessed the gene ontology terms of genes that were alternatively spliced upon Ptbp1 silencing (Fig. 3n , o and Extended Data Fig. 9c -i). In addition to altering the splicing patterns of genes related to cardiomyocyte lineage and function ( Fig. 3n ), Ptbp1 silencing resulted in changes in the splicing pattern of 21 other splicing factors, suggesting that Ptbp1 knockdown might trigger a second wave of splicing changes by regulating the switching of the isoform of other splicing factors. Furthermore, we explored the potential downstream effects of Ptbp1mediated re-patterning of splicing events ( Supplementary Table 6 and Supplementary Discussion 3). DESeq2 (ref. 22) analyses of differentially expressed genes revealed that Ptbp1 knockdown enhanced the MGT-induced cardiac fibroblast to cardiomyocyte transcriptome shift by augmenting MGT-mediated changes ( Fig. 3p and Extended Data Fig. 9j -n) and altering the expression of an additional set of cardiac and fibroblast lineage genes ( Fig. 3q and Extended Data Fig. 9o ).
To determine whether cardiac reprogramming is a rare and random event or a Mef2c-, Gata4-and/or Tbx5-determined process, we plotted the expression of Mef2c, Gata4, Tbx5 and M + G + T in each cell against the reprogramming pseudotime of that cell calculated by SLICER ( Fig. 4a and Extended Data Fig. 9p ). We found that the expression levels of Mef2c, Gata4, Tbx5 and M + G + T are highly correlated with the reprogramming progress, despite the fact that their expression was not used in the generation of the trajectory. We also determined the mean expression levels of Mef2c, Gata4 and Tbx5 and the mean ratio of expression (Mef2c/Gata4, Mef2c/Tbx5 and Gata4/Tbx5) in the fibroblast, intermediate fibroblast, pre-iCM and iCM populations along the reprogramming trajectory (Extended Data Fig. 9q -s). Consistent with our previous studies 6,14,23 , we observed higher levels of Mef2c than Gata4 and Tbx5 in iCMs, further underscoring the importance of high Mef2c expression in iCM induction.
To unravel the gene networks regulated by reprogramming factors, we navigated the relationship between the expression of a reprogramming factor and its downstream targets in each single cell. Using Tbx5 as an example, we calculated the Spearman correlation between Tbx5 expression and the expression of its downstream targets 24,25 within each reprogramming cell ( Fig. 4b, left ). We then generated a correlation matrix for selected Tbx5 targets to determine their co-expression patterns (Fig. 4b , right). The correlation patterns suggest that Tbx5 acts by promoting cardiac function-related genes and by suppressing protein biosynthesis and non-cardiomyocyte lineages ( Fig. 4b and Extended Data Fig. 9t, u) .
Finally, we aimed to discover novel markers for targeting or enriching cell populations during iCM induction. To identify specific markers for each cell population along the reprogramming trajectory, we selected genes that were expressed significantly higher (for positive selection markers) or lower (for negative selection markers) in the cell population of interest than the other three populations (Tukey-adjusted P value < 0.05 in pairwise comparisons after ANOVA; Extended Data Table 7 ). Negative selection markers for iCMs appeared the most attractive as a supplement to cardiac positive selection markers. Among the top 20 negative markers for iCMs, we focused on four surface markers, Cd200, Clca1, Tm4sf1 and Vcam1 (Fig. 4c ). Linear regression analysis suggests that the expression of these markers was highly anti-correlated with the reprogramming process and was barely detectable in iCMs ( Fig. 4d ). Further experimental validation confirmed that Cd200 was a negative selection marker ( Fig. 4e, f) , and knockdown of Cd200 did not affect reprogramming efficiency (Extended Data Fig. 10g-n) . Microtubule (24) Cardiac muscle contraction (10) Endoplasmic reticulum (58) Adrenergic signalling in CM (18) mRNA splicing (21) Calmodulin binding (22) Sarcoplasmic reticulum (12) Kinase (53) Endocytosis (19) Cell junction (65)
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We have used single-cell transcriptomics analysis to gain insights into the heterogeneity of cells within an unsynchronized cardiac reprogramming system. The findings show promise for improving the efficiency and detection of iCM formation. We also anticipate that the experimental and analytical methods presented here, when applied in additional cell programming or reprogramming contexts, will yield crucial insights into cell fate determination and the nature of cell type identity.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Supplementary Table 8 . pBabe-Zeo-LargeT was purchased from Addgene (1779). The non-targeting shNT pLKO.1-scramble plasmid was described previously 26 and all other shRNAs (pLKO.1-vector based, MISSION shRNA glycerol stock) were purchased from Sigma and their TRC numbers are listed in Supplementary Table 8 . Isolation of neonatal cardiac fibroblasts and cardiomyocytes, and generation of iCM. We chose to reprogram mouse neonatal cardiac fibroblasts, which were used in the first 1 and many of the subsequent cardiac reprogramming studies 2-6,8,12,14,15,23,27 . Cardiac fibroblasts were isolated using standard protocols described previously 23, 27 . Specifically, neonatal (postnatal day (P)1.5) hearts were isolated from α -MHC-GFP + pups and rinsed thoroughly with chilled phosphate-buffered saline (PBS). The hearts were then minced by a razor blade, transferred to 8 ml warm 0.05% Trypsin-EDTA (Gibco), and incubated at 37 °C for 10 min. After five rounds of collagenase digestion (5 ml of warm 0.2% collagenase type II in HBSS for 3 min at 37 °C followed by vortexing for 1 min), a single-cell suspension was obtained by passing through 40-μ m cell strainers. The cells were then suspended in 1 ml of red-blood-cell lysis buffer (150 ml NH 4 Cl, 10 mM KHCO 3 and 0.1 mM EDTA) for 1 min on ice and resuspended in magneticactivated cell sorting buffer (MACS buffer: DPBS, 0.5% BSA, 2 mM EDTA). To sort Thy1 + cells, approximately 1 × 10 7 cells were suspended in 90 μ l MACS buffer with 10 μ l Thy1.2 micro-beads (Miltenyi Biotec) at 4 °C for 30 min. The cells were then washed, suspended in MACS buffer and applied to an equilibrated LS column (Miltenyi Biotec). Cells bound to beads were flushed out after two washes and seeded onto 0.1% gelatin-coated plates at 2.5 × 10 4 per cm 2 in fibroblast medium (IMDM, 20% FBS, 1× penicillin-streptomycin). After overnight culturing, the medium was replaced to remove unattached cells. We refer to the MACS-isolated Thy1 + adherent non-cardiomyocytes as neonatal cardiac fibroblasts. For bulk RNA-seq experiments, neonatal cardiac fibroblasts were similarly isolated, except that MACS-isolated Thy1 + cells were directly lysed in TRIzol (Life Technology) without culturing. Neonatal cardiomyocytes were isolated using the neonatal cardiomyocytes isolation system (Worthington Biochemical Corporation) except that all enzymes were used at a quarter of the recommended concentration to increase cell viability. After a 1.5 h of pre-plating on an uncoated surface to remove attached non-cardiomyocytes, the unattached cardiomyocytes were collected in TRIzol (> 80% viability by Trypan blue staining). For iCM generation, pMXs retroviruses were packaged by transfecting platE cells (Cell Biolabs) with Lipofectamine 2000 (Life Technology) as previously described 14 . Viruses collected from one 10-cm dish were resuspended in 100 μ l iCM medium (10% FBS in DMEM:M199 (4:1)) and added to cells at 5 μ l of each virus (if cotransducting) per cm 2 of surface area. All transductions were performed in iCM medium containing 4 μ g ml −1 of polybrene. For single-cell RNA-seq, cardiac fibroblasts were untransduced, transduced with a 1:2 ratio of pMXs-DsRed:pMXs (LacZ) or transduced with equal amounts of Mef2c, Gata4 and Tbx5 viruses. For microarray experiments, cardiac fibroblasts were transduced with the control pMXs-puro (LacZ) or the pMXs-puro-MGT viruses and collected in TRIzol. Day 5, 7, 10 and 14 samples were selected with 2 μ g ml −1 puromycin from day 3 and maintained in 1 μ g ml −1 puromycin from day 6. Day-0 samples were overnight-cultured cardiac fibroblasts that were collected immediately before viral transduction. For bulk RNA-seq, cardiac fibroblasts were transduced with pMXs-puro (LacZ), pMXs-puro-MGT, pMXs-puro-MGT + shNT or pMXs-puro-MGT + shPtbp1-271 for three days and then collected in TRIzol. All microarray and bulk RNA-seq samples were prepared in duplicate. Capture of single cells, RNA spike-ins and preparation of cDNA. Single cells were captured using the Fluidigm C1 system (up to 96 single cells per plate). A total of seven individual experiments (E1-E7) were performed starting from mouse breeding, cardiac fibroblast isolation, iCM reprogramming, to single-cell capture and cDNA preparation (see Extended Data Fig. 1 for experimental design and workflow). Three of the seven experiments (E1, E2 and E4) contained only M + G + T-transduced cells. Four of the seven experiments (E3 and E5-E7) contained cells treated with two different conditions in order to estimate the relative abundance of mouse mRNA between treatments. Specifically, for experiments E1, E2 and E4, cardiac fibroblasts transduced with M + G + T for 3 days were collected by trypsinization, stained with 7AAD or NearIR Live/Dead dye (Thermo Fisher Scientific), and FACS-sorted for live cells (negative for the Live/Dead dye). Pilot experiments showed an average diameter of 12.6 μ m and a buoyancy of 7.5:2.5 (cells:buoyancy buffer) of cardiac fibroblasts. Therefore, the sorted single-cell suspension (around 2,000 cells per μ l) was loaded on a medium-sized (10-17 μ m) microfluidic RNA-seq chip (C1 Single-Cell mRNA Seq IFC, 100-6041, initially designed chips were used in E1-E3 and redesigned chips were used in E4-E7) and single cells were captured with the C1 system. Bright field images were taken of each capture site. For experiments E3 and E5-E7, day-3 M + G + T-transduced (E5 and E6) or untransduced (E3 and E7) cardiac fibroblasts were stained with the NearIR Live/Dead dye and 0.25-1 μ M carboxyfluorescein succinimidyl ester (CFSE, Thermo Fisher Scientific), whereas the DsRed-transduced cardiac fibroblasts were stained with the NearIR Live/Dead dye only. Then, 12,000 CFSE-and NearIR-stained green fluorescent cells and 12,000 DsRed-and NearIR-stained red fluorescent cells were sequentially FACS-sorted into the same tube and mixed. For experiment E3, cell sorting was slightly different, and 700 of each of the CFSE single-positive cells (untransduced), DsRed single-positive cells (DsRedtransduced) and double-negative cells (from the DsRed-transduced wells but with no DsRed protein expression) were sorted into a single-cell suspension. After cell capture, fluorescent images of GFP and RFP channels as well as bright field pictures were taken.
Next, control RNA spike-ins were added into lysis mix A (see Fluidigm's protocol), which were then loaded onto the IFC plate before cell lysis. Experiments E1 and E2 used the Ambion Array Control spike-ins (AM1780) that were included in the SMARTer kit. E1 used only spike 1, 4 and 7 according to Fluidigm's protocol but at a concentration that is 100-fold higher than suggested, based on recommendations from the UNC Advanced Analytics Core (AAC) that provided the Fluidigm service. E2 used all 8 spike-ins contained in the kit at the following working concentrations (before addition to lysis mix A): 10 pg μ l −1 of spike 1, 1 pg μ l −1 of spike 2 and with a 10-fold reduction for the next spike and so on. For E3, we used the Ambion spike-ins at half the concentration of those used in E2 and another spike-in, the External RNA Controls Consortium (ERCC) RNA spike-in Mix 1 (Ambion, Life Technologies) after an 80,000-fold dilution. For E4-E7, only the ERCC spike-in was used after a 40,000-fold dilution and 1 μ l of the diluted working spike-in was mixed with 19 μ l of other components to make lysis mix A. Then cell lysis, reverse transcription and cDNA pre-amplification were performed on the chip according to Fluidigm's standard protocol and the control RNA spike-ins were processed in parallel with cellular RNA. Differences in spike-ins added to each experiment reflected how the technology evolved over time during the progress of this project. To address the spike-ins issue, among others, we developed a pipeline described in the 'Processing and normalization of single-cell RNA-seq data' section to normalize and analyse all acquired useful data. Illumina library preparation and sequencing. After in situ cDNA library preparation, the bright field and fluorescent images of each capture site (nest) on the chip were carefully examined. Forty-six empty nests, 30 nests with two or more cells, and 22 nests containing morphologically unhealthy cells out of 672 capture sites on seven chips were excluded from further analysis, resulting in 574 single-cell cDNA libraries. The size distribution and quality of cDNA libraries from each single cell were ensured by bioanalyzer. For E3 only, cDNA library concentrations
were measured with picogreen (Thermo Fisher Scientific) and four single-cell cDNA libraries below 1 ng μ l −1 were excluded from further analysis. E1-E4 each contained a negative control from an empty nest that was processed in parallel with other healthy single cells. Therefore a total of 574 high-quality cDNA libraries were submitted to the UNC High Throughput Sequencing Facility (HTSF). Illumina libraries were prepared using the Nextera XT DNA Sample Preparation kit according to Fluidigm's standard protocol, except 13 cycles of amplification were carried out. The barcoded single-cell Illumina libraries of each experiment were pooled and sequenced for 50-bp single-end reads on Illumina HiSeq 2500. Illumina library preparation and sequencing were carried out in three batches: E1 by itself on two lanes, E2 and E3 processed together on one lane each, and E4-E7 processed together on one lane each. Previous studies showed that 0.5-1 million reads per cell were sufficient to detect most genes expressed by single cells 28, 29 . In this study, we sequenced the cells at about 1-5 × 10 6 reads per cell. Raw reads were re-assigned to each single cell by their unique Nextera barcode and sequencing reads without barcodes were received from the HTSF in.fastq format.
For microarray and bulk RNA-seq samples, cellular RNA was extracted with TRIzol (microarray samples were further purified with the RNAeasy kit from Qiagen), and only samples with an RNA integrity number (RIN) above 8, as determined using a bioanalyzer, were further processed. Microarray samples were submitted to the HTSF for one-colour Cy-dye labelling and long oligo (60-mer) Agilent high-density microarrays. Bulk RNA-seq samples were prepared with the TruSeq Stranded mRNA Library Prep Kit (Illumina). The barcoded Illumina libraries were pooled and submitted to the HTSF for sequencing. About 6 × 10 7 100-bp paired-end reads per sample were obtained and sequencing reads removed of Illumina indexes were received from HTSF in.fastq format. Processing and normalization of single-cell RNA-seq data. The quality of sequencing results was first checked by FASTQC. Reads were high quality and no trimming was required. The raw reads were then mapped to the merged genome of mm10, ERCC, and E. coli K12 with TopHat2 using default settings. Information about the number of total reads and the percentages of reads mapped to spike-in or mouse genome for each single cell are detailed in Supplementary  Table 1 . Outliers showing high ratios of percentage reads mapped to spike-in to percentage reads mapped to mouse genome were removed (Extended Data Fig. 1d ). This step removed 61 outliers from the 574 sequenced single cells, resulting in 513 high-quality single cells for analysis ( Supplementary Table 2 ). Gene expression was counted with Htseq-count using the union mode 30 (http://www-huber.embl.de/users/anders/HTSeq).
Limit of detection of our single-cell RNA-seq was determined as previously described 28 . In brief, the concentration of each ERCC spike-in in the lysis chamber was first calculated. For experiment E3, seven of the spike-ins were present at 1.24 molecules per chamber and were as follows: ERCC-00014, ERCC-00028, ERCC-00039, ERCC-00067, ERCC-00077, ERCC-00143 and ERCC-00150. For experiments E4-E7, five of the spike-ins were present at 1.24 molecules per chamber and were as follows: ERCC-00031, ERCC-00033, ERCC-00058, ERCC-00069 and ERCC-00134. The number of non-zero measurements of each spike-in was then counted. This number was divided by the total number of high-quality cells from that plate and this is the probability of detection for each spike-in at this concentration. Mean probability of detection of all 12 spike-ins is 0.30, consistent with previous findings 28 and suggesting single-molecule sensitivity of our experiments.
We developed a three-step normalization strategy in order to extract biologically meaningful information from all the single-cell RNA-seq data (Extended Data Fig. 1c ). Firstly, we normalized mouse gene raw counts to each cell's technical and biological size factors within each experiment using a previously described method 31 . These two size factors account for technical variations within each experiment, such as amplification efficiency and differences in the amount of biological starting material in each cell. On the basis of the normalized DsRed counts, cells in experiments that involved two treatments were classified as DsRed-transduced (E3R, E5R, E6R and E7R, expressing high levels of DsRed), or M + G + T-transduced (E5M, E6M) or untransduced cells (E3U, E7U; Extended Data Fig. 1g ).
Secondly, we corrected for 'batch effects' that account for technical contributions to experiment-to-experiment variations due to different cell-capture efficiency, types/amounts of spike-ins and Fluidigm chips (Extended Data Fig. 1b ), while preserving biological information, such as total mRNA abundance. By comparing biological replicate experiments, we found different mean total mRNA counts per cell (Extended Data Fig. 1h ) that probably resulted from varying cell-capture efficiency per plate (68 sequenced cells in E5, 33% more compared to 51 cells in E6; Supplementary Table 2 ), various amounts of spike-ins used (100-fold more concentrated spike-ins in E1 than in E2) and different types of spike-ins and Fluidigm chips used (Fluidigm spike-in and previous chip in E2 and ERCC spike-in and redesigned chip in E4), suggesting the existence of batch effects.
To determine whether different treatments affected mouse mRNA abundance in the cell, we also examined mean total mRNA reads from different treatments in the same experiment (Extended Data Fig. 1h ). We found no difference in mean total mRNA counts between uninfected and DsRed-transduced cells (E3U versus E3R and E7U versus E7R) but 40% less counts in cells undergoing reprogramming (M + G + T-transduced, E5M, E6M) than DsRed-transduced cells (E5R, E6R), suggesting biological variations caused by treatment. Therefore, to retain mRNA abundance information while correcting for batch effects, we normalized each treatment in each experiment to an experiment size factor so that the median mRNA counts equals 1,000,000 for uninfected and DsRed-transduced cells and 616,136 (deduced from the ratio of median mRNA counts from M + G + T transduction to DsRed transduction (M:R) of E5 and E6) for M + G + T-transduced cells (Extended Data Fig. 1h ). This normalization successfully removed the batch effects discussed above. An example is shown in Extended Data Fig. 1i comparing cells from E5 and E6 on a PCA plot.
Lastly, we focused on non-immune cells (462 cells in total, see Extended Data Fig. 3 for details) and removed residual batch effects using ComBat, a method that was designed for normalizing gene expression data 32 and that performed well in previous studies 33 . After examination of all experiments in each treatment condition with PCA plots (Extended Data Fig. 2a -c, the 'Before' columns), we found no batch effects in the principal component (PC)1/PC2 plot, but started to see incomplete overlap of different experiments in PC3 (for uninfected cells) or PC4 (for M + G + T-and DsRed-transduced cells); PC3 and PC4 only represented < 5% variance of the data. Because batch effects were observed between different chips, but not within the same chips, we postulated that the use of two different versions of the Fluidigm medium-size chips might be the cause. The ComBat normalization was run separately for each treatment to remove only technical variations between batches while preserving biological variations between treatments. ComBat requires all input genes to be expressed in all batches, that is, at least one cell in each batch. Therefore, genes that have non-zero counts in all batches were selected and normalized for each treatment. After the normalization, results from different treatments were merged. For those genes that were selected in one treatment but not others, expression levels were set to 0 in other treatment(s). After this procedure, there were a total of 14,414 genes left. PCA analyses with ComBat-normalized counts showed that no batch effects were detected in the top 20 PCs (the ' After' columns in Extended Data Fig. 2a -c for PC1-PC4, and data not shown), suggesting successful removal of all residual batch effects in our data. Analysis of single-cell RNA-seq data. Outlier detection, PCA, hierarchical clustering and the generation of violin plots were performed with the 'SINGuLAR Analysis Toolset' package (Fluidigm) in R. First, normalized expression was log 2 -transformed before analysis. Outliers were detected and removed based on mean gene expression and PCA using the SINGuLAR package (Extended Data Fig. 2d, e ), resulting in 454 high-quality non-immune cells for downstream analysis. Expression of the reprogramming factors Mef2c, Gata4 and Tbx5 was excluded before PCA, hierarchical clustering or SLICER (see 'Trajectory construction and identification of genes related to iCM reprogramming') analysis. Next, the top 400 PCA genes were selected by largest weight (loading) contribution to PCs 1, 2 or 3. Then hierarchical clustering was performed with these 400 genes and cells were grouped as fibroblasts (fibroblasts from control plates), intermediate fibroblasts (fibroblasts from M + G + T plates), pre-iCMs (cells expressing both cardiac and fibroblast markers) and iCMs (Fig. 1a) . The group information was used to generate PCA plots (Fig. 1b, c) , violin plots (Extended Data Fig. 4b, l) and to perform analyses of variance (ANOVA; Fig. 4c, d and Extended Data Fig. 10a-e ). ANOVA and Tukey post hoc tests were performed with custom scripts in R in order to identify positive-or negative-selection markers for iCM and pre-iCM. For ANOVA, CCI but not CCA cells were used. For violin plots in Figs 2, 4, box plots were overlaid over the violin plots. The centre dot represents median gene expression and the central rectangle spans the first quartile to the third quartile of the data distribution. The whiskers above or below the box show the locations of 1.5× interquartile range above the third quartile or below the first quartile. t-distributed stochastic neighbour embedding (tSNE) analysis was performed with the 'Rtsne' package in R. Gene ontology analysis was performed using the DAVID functional annotation tool version 6.7 (https://david.ncifcrf.gov/). All gene ontology terms shown in this study have a P value or corrected P value (FDR) < 0.05. For the comparison of distributions of number of detected genes in different cell groups, we conducted a one-sided two-sample Kolmogorov-Smirnov test (Extended Data Fig. 4n, o) . Because we are comparing the distributions of two samples, the conclusion is more general than a mean test, such as a t-test, and does not rely on restrictive statistical assumptions, such as normal distributions.
In Fig. 2a -c, cells from experiments E1-E3 are shown. Analysis of data from experiments E4-E7 showed consistent results (Extended Data Fig. 6e, f, k) . For Fig. 2c , first, CCI and CCA cells in fibroblasts or epicardial-like cells (Fig. 2a, b and Supplementary Discussion 1) were merged into one Fb/Epi group. Then a new hierarchical clustering for control cells in E3 was calculated using the four cell-lineage-related gene clusters but not the cell cycle genes identified in Fig. 2a . The calculated hierarchical clustering was very similar to that in Fig. 2a and was applied to reprogramming cells from E1 and E2 to generate Fig. 2c . For all correlation analyses, gene expression was always log-transformed before analysis. In Fig. 4a, d and Extended Data Fig. 9p , CCI cells were used. Linear regression was performed to obtain the regression coefficient (R value) and its corresponding P value (two-sided, α = 0.05). For correlation analysis of Tbx5 and its target genes in Fig. 4b , M + G + T-transduced CCI cells were included. The list of Tbx5 ChIPseq peaks in HL-1 and the list of genes differentially expressed in wild-type versus Tbx5-null mutant mice hearts were obtained from previous studies 24, 25 . Genes present in both lists (2,109 genes) were selected as Tbx5 downstream targets and used to calculate Fig. 4b . A total of 170 genes with a Spearman correlation coefficient > 0.3 or < -0.3 were selected and their correlation coefficient with Tbx5 is plotted in Fig. 4b (left) . Then intercorrelation between these genes was calculated and the correlation matrix ordered by hierarchical clustering is shown as a heat map in Fig. 4b (right) . Three sets of genes A, B, C were found to be co-expressed (P < 2.6 × 10 -6 by Spearman correlation). Representative genes of these sets are listed on the right and their corresponding gene ontology terms were labelled on the left (Fig. 4b) . For correlation analysis of Mef2c, Gata4 and Tbx5 expression and expression of transcription factors or splicing factors, M + G + T-transduced CCI cells are shown in Extended Data Fig. 9t , u. The list of mouse transcription factors was obtained from public databases as previously described 12 and the list of splicing factors was obtained from a previous study 34 . Trajectory construction and identification of genes related to iCM reprogramming. We used SLICER (selective locally linear inference of cellular expression relationships) 17 , an algorithm that we have previously developed, to construct cellular trajectories of iCM reprogramming. SLICER is implemented as an R package, which is freely available on the Comprehensive R Archive Network (CRAN) and on GitHub (https://github.com/jw156605/slicer). In brief, SLICER discovers a nonlinear, low-dimensional manifold embedded in gene expression space that indicates how cellular gene expression profiles change during a sequential process. Additionally, SLICER automatically detects the presence, location and number of branches in a trajectory, corresponding to multiple cell fates or multiple cellular processes occurring simultaneously. Here, the manifold corresponds to the reprogramming process by which fibroblasts turn into iCMs. To ensure consistency between the clustering and trajectory analyses, we ran SLICER on the control and reprogramming cardiac fibroblasts using the top 400 PCA genes, rather than using SLICER's gene selection approach. We performed nonlinear dimensionality reduction using a technique called local linear embedding (LLE), which is analogous to a nonlinear version of PCA. Here, we used a three-dimensional LLE projection for trajectory construction. We then build a k-nearest neighbour graph in the low-dimensional manifold space produced by LLE. Shortest paths through the neighbour graph correspond to geodesics along the manifold, and we use the lengths of these shortest paths to order cells according to their distances from a user-defined starting cell. The steps of the reprogramming process can then be traced by examining the cells one-by-one in the specified ordering. We also investigated the distribution of cells along pseudotime, reasoning that local differences in density could indicate the relative speed of changes and stability of intermediate states. We estimated the density of cells in pseudotime using a Gaussian kernel density estimator, then calculated the free energy as max (density) -density. Nonproliferating M + G + T-transduced cells were used for free energy calculation (Fig. 1f) .
Using a method similar to the previously described method of ref. 35 , we used nonlinear regression to identify genes that are significantly related to the reprogramming process. Only non-proliferating cells were included in this analysis. For each gene with mean expression above 1, we fit a generalized additive model (GAM) of the Tobit family (VGAM R package). The GAM approach uses cubic splines to fit a smooth nonlinear model, and the Tobit likelihood accounts for zero inflation by modelling gene expression dropout as data censoring. To avoid overfitting the data, which would result in a curve that is too 'wiggly' , we constrained the GAM fits to use three degrees of freedom. We then identified genes that were significantly related to the reprogramming process using a likelihood ratio test, with a constant GAM as the null model. Using k-medoid clustering (pam algorithm from the cluster R package), we identified clusters of significantly related genes that showed similar trends over the reprogramming process ( Fig. 3a and Extended Data Fig. 7a ). Analysis of bulk RNA-seq and microarray data. Bulk RNA-seq data were analysed similar to single-cell data, except that they were only normalized for sequencing depth. Specifically, raw counts from the HTseq count were divided by the total number of mm10 mRNA reads from that sample and then multiplied by 1 × 10 6 to give counts per million. For differential expression analysis of LacZ versus MGT samples and MGT and shNT versus MGT and shPtbp1 samples, raw counts were inputted into DESeq2 (ref. 22) in R and lists of differentially expressed genes were obtained (FDR < 0.05, fold change > 1.25). Heat maps were generated using the heatmap.2 function in the 'gplots' package in R. The microarray data were processed using the limma package of Bioconductor 36 . Raw data were first background-corrected and normalized using 'normexp' and 'quantile' methods, respectively. Next, control probes and low-intensity probes were filtered out using the 1.1 multiplier of the 95% quantile for negative controls as a cut-off. Lastly, probe intensity data were log 2 -transformed and replicated probes for each gene were averaged for subsequent analyses. PCAs were performed in R with the 'prcomp' function using all of the 34,378 detected genes and the 3D plot was generated with the 'scatterplot3d' package in R (Extended Data Fig. 4p, q) . Analysis of splicing. We aligned the bulk RNA-seq data (100-bp, paired-end reads) to mm10 using Mapsplice version 2.1.4. To detect alternative splicing, we used rMATS 37 version 3.2.5 with Ensembl GRCm38.82 gene annotations and the novelSS (novel splicing site) flag to identify unannotated splicing events. All other rMATS parameters were set to the default values. In Fig. 3j -l, n, o and Extended Data Fig. 9a -i, we used FDR < 0.05 and Δ PSI > 15 as cut-offs, resulting in 1,494 alternative splicing events for MGT and shPtbp1 versus MGT and shNT, and 879 alternative splicing events for MGT versus LacZ (see Supplementary Tables 4, 5 ). In Fig. 3j , k, to determine whether the direction (sign) of PSI change is consistent between two group pairs, we identified the overlapping alternative splicing events between the samples (69 overlapping events between MGT versus LacZ and cardiomyocytes versus cardiac fibroblasts, and 155 events between MGT and shPtbp1 versus MGT and shNT, and cardiomyocytes versus cardiac fibroblasts). We then conducted a binomial test by first transforming the paired Δ PSI data into either + 1 or − 1 based on if their signs agreed or not, and then calculating the proportion of + 1's and compare it to 50% using a one-sided binomial test. The results for Δ PSI (cardiomyocyte-cardiac fibroblasts) versus (MGT-LacZ) showed that for only 34.78%, the signs in these two groups agree with each other (P = 0.0077). Therefore, we conclude that there was enough statistical evidence to support that the directions (signs) in cardiomyocyte-cardiac fibroblasts and MGT-LacZ are different. The result for cardiomyocyte-cardiac fibroblasts versus shPtbp1-shNT shows that for 83.22% the signs in two groups are the same (P = 2.2 × 10 −16 ). Therefore we conclude that there is enough statistical evidence to support that the directions (signs) in cardiomyocyte-cardiac fibroblast and shPtbp1-shNT are the same. To plot the positional distribution of Ptbp1-binding motifs, we used rMAPS 21 version 1.0.5. The rMAPS tool can only be used for exon-skipping events and has a database of known binding motifs for RNA-binding proteins, including Ptbp1. It considers exon-skipping events with FDR < 0.05 and Δ PSI > 5 as statistically significant and all others insignificant. Then it takes all exon-skipping events (both significant and insignificant) and uses the events that are not significant to create a background profile. We basically extracted the exon skipping events from the rMATS comparison of MGT and shPtbp1 versus MGT and shNT and ran rMAPS on this list to generate Fig. 3m . Proliferation assays. Lentiviruses were packaged by transfecting HEK293T cells with Lipofectamine 2000 as previously described 12 . For packaging shRNA viruses, a total of 10 μ g plasmids consisting of equivalent concentrations of each of the four or five shRNA targeting different regions of the gene were used. Lentiviral Mef2c, Gata4, Tbx5, inducible MGT (iMGT) and large T antigen were added to cells at 5 μ l of each virus (if co-transduction) per cm 2 of surface area and all other lentiviruses (rTtA, LacZ, cell-cycle related genes and shRNA) were used at 2.5 μ l per cm 2 . For Extended Data Fig. 5b -m, pMXs-puro-MGT was used for iCM induction. In the EdU-incorporation assay, cells were pulsed with 10 μ M of EdU for three days before staining with Alexa Fluor 647-labelled EdU of the Click-iT Plus Edu Alexa Fluor 647 Flow Cytometry Assay Kit (ThermoFisher Scientific, C10634). Propidium iodide (Life Technologies, P3566) staining was performed as previously described 19 . For iMGT induction, doxycycline was added at 1 μ g ml −1 and the medium was changed every 2-4 days. Puromycin (puro) selection was performed at 1 μ g ml −1 and the medium was changed every 2-4 days. For the cell-cycle synchronization assay, cardiac fibroblasts were treated with 400 ng ml −1 of nocodazole (G2/M) or cultured in a low serum condition (0.5% FBS, G0/G1) for four days before iCM induction; the normal serum condition was 10% FBS. To generate CF-T cells, neonatal cardiac fibroblasts were transduced with pBabe-largeT and selected using 600 ng ml −1 Zeocin in fibroblast medium (IMDM, 20% FBS, 1× penicillin-streptomycin) from day 2 for two weeks. The resulting CF-T cells were a relatively homogenous pool of cells after antibiotic selection. All data are representative of multiple repeated experiments. shRNA library screen, immunofluorescence staining, flow cytometry and qRT-PCR. For screening of the shRNA library targeting splicing factors, MGT expression was induced by 1 μ g ml −1 doxycycline in icMEFs 19 that constitutively express Tet and the MGT construct under the control of a Tet-ON promoter. Lentiviruses containing mixed clones of shRNAs targeting each gene were added to the cells at 5 μ l per cm 2 . For Ptbp1 protein expression, western blotting was
Extended Data Figure 1 | Experimental design, analysis pipeline, quality control and normalization for single-cell RNA-seq. a, Experimental workflow. Hearts were isolated from P1.5 neonatal mice and cells were dissociated by enzymatic digestion. Thy1 + cells were then purified by MACS and plated overnight. The adherent cells (cardiac fibroblasts) were then transduced with retroviruses encoding the reprogramming factors Mef2c, Gata4 and Tbx5, DsRed or were left untransduced (mock). On day 3 after transduction, cells were trypsinized and Live/Dead stained. Additionally, for some experiments designed to examine the relative mouse RNA abundance in cells receiving different treatments, mock and M + G + T cells were labelled with a green cell tracker (CFSE), FACS-sorted for live cells, and then mixed at a designated ratio with FACS-sorted live DsRed + cells from a parallel DsRed transduction. The single-cell suspension was loaded onto a medium size chip (10-17 μ m) and single cells were captured on a Fluidigm C1 machine. Bright field, and for some experiments, fluorescent images, were taken for all capture sites. Individual cDNA libraries for each cell were prepared in situ by reverse transcription with pre-amplification after adding RNA spike-in. Bright field and/or fluorescent images for each capture site were examined and libraries from nests with 0 or multiple cells were excluded from downstream analysis. Illumina libraries were then prepared for each cell, pooled, quality-checked and sequenced on Hiseq 2500. b, Design of the seven independent single-cell RNA-seq experiments, including treatment, RNA spike-ins and Fluidigm chips used. c, Data analysis pipeline. Barcodes were trimmed from RNA-seq raw reads and the quality of these reads was confirmed with FASTQC. High-quality reads were mapped to the mm10 genome with TopHat2 and counted with Htseq count. Outliers were removed as described in d. The raw counts were normalized first to technical and biological size factors within each experiment using DEseq and then to experiment size factors calculated based on relative mouse mRNA abundance in cells receiving different treatments (h). Residual batch effects between experiments receiving the same treatment were removed using ComBat. Cell grouping and modelling were then performed using the normalized gene counts with PCA, hierarchical clustering, SLICER and more. The most important three quality control steps are labelled in red in a and c. The above strict quality control criteria ensured that only high-quality and biologically meaningful data from healthy single cells were analysed. d, For each of the seven single-cell experiments, the percentage of reads mapped to spike-in in each cell was plotted against percentage of reads mapped to mouse genome (left) or mouse mRNA (right) in that cell. Cells outside of the red circles are outliers. e, For each of the five single-cell experiments that contained ERCC spike-in, mean count numbers of each ERCC spike-in were plotted against their concentration in lysis mix A (see Fluidigm's protocol for details). Linear regression coefficients (R value) and corresponding P values (two-sided, α = 0.05) are shown. The results showed a dynamic range (~ 10 5 ) of ERCC concentration that covers the full spectrum of mouse gene expression levels. The high R values indicate a strong correlation between hypothetical molecular concentrations and measured gene counts in our experiments. f, Squared coefficients of variation (CV 2 ) were plotted against mean expression of ERCC spike-ins (left) or mouse genes (right) for experiments containing ERCC spike-in. g, DsRed counts in experiments E3 and E4-E7 plotted against Mef2c counts and/or total mouse mRNA counts after normalization for technical and biological size factors within each experiment (Methods). Cells in the four experiments were classified as DsRed-transduced (E3R, E5R, E6R, E7R), M + G + T-transduced (E5M, E6M) or untransduced cells (E3U, E7U) based on these plots. h, i, Normalization to experiment size factors to account for technical contributions to experiment-to-experiment variations, such as varied capture efficiency, while retain biological variations, such as differences in total mRNA abundance in cells receiving different treatments. h, Median total mouse mRNA counts were calculated for each treatment in each experiment and mean mRNA counts were compared between different experiments (E1, E2 and E4) or different treatments in one experiment (E3, E4-E7) with a two-sided Student's t-test (α = 0.05). Experiment size factors were calculated based on the ratio of median mRNA counts between different treatments. After normalization to the experiment size factors, the median mRNA count was equal to 1,000,000 cells for uninfected and DsRed-transduced cells and 616,136 cells for M + G + T transduction. i, PCA of two biological replicates (E5 and E6) that have different sequencing depth per cell due to different capture efficiencies before (left) and after (right) normalization to experiment size factors. Top 400 PCA genes were used. To identify groups of related cells and genes, the top 400 genes with highest weight in the first three principal components were then analysed by unsupervised hierarchical clustering (a) and PCA (b, c). Representative genes in each of the four gene clusters identified by hierarchical clustering are listed to the right of hierarchical clustering heat map. Notably, in addition to cardiomyocyte, fibroblast and cell-cycle genes, immune response genes were identified as the other major gene cluster. b, PCA loading plot showing four major gene clusters. c, PCA score plot. Both hierarchical clustering and PCA results showed that bulk cardiac fibroblast and cardiomyocyte data were very close in distance and both of them were clustered together with single cells expressing high levels of immune genes. The dashed line separates immune-like single cells and other single cells. d, Markers of the major immune cell lineages. e, Violin plots of the expression of major immune cell lineage markers in bulk cardiac fibroblasts, bulk cardiomyocytes, immune-like single cells and other single cells. f, Expression of the macrophage marker Cd14 and the dendritic cell marker Cd11c (also known as Itgax) in each immune-like cell showed that 42 cells express macrophage markers and 3 express dendritic cell markers, with 4 cells expressing both. These data suggest that the immune-like cells are probably cardiac resident immune cells 38 , which also express cardiac fibroblast markers, such as Thy1. Although follow-up work to delineate the potential of these immune cells to be reprogrammed into iCMs will be of great interest, it is not the focus of this study. Therefore, for all subsequent analyses of the single-cell data, we focused on the non-immune cardiac fibroblasts. (Fig. 1a-c) . c, Gene ontology analysis from Fig. 1a showing the P value of each gene ontology term. d-g, Determination of the proliferation status of each single cell using genes periodically expressed during the cell cycle that were identified in a previous report 39 . d, A 3D LLE plot calculated based on the expression of these cell cycle genes in each of the 454 cells. e, Frequency of cells in LLE component 3. The dark red plane in d and the red dotted line in e indicate the threshold for proliferating (Pro) and non-proliferating (NP) cells. f, g, PCA plots as in Fig. 1c , but colour-and shape-coded for proliferating and non-proliferating (f) or CCA and CCI (g) cells. h, i, tSNE plots of all single cells colour-and shape-coded by hierarchical clustering and PCA cell groups (h) or proliferating and non-proliferating cell groups (i). The cells that were grouped as intermediate fibroblasts, pre-iCMs and iCMs constituted 30.6% (77 out of 252), 24.6% (62 out of 252) and 44.8% (113 out of 252) of all cells transduced with M + G + T, respectively. In contrast to previous population-and marker-based studies, our singlecell RNA-seq data suggests that the fate conversion from fibroblast to iCM occurs rapidly (approximately 3 days) with nearly 45% of the cardiac fibroblasts exhibiting transcriptomic signatures indicative of a cardiac fate. j, Live fluorescent images of day-5 MGT-transduced cardiac fibroblasts showing co-expression of α -MHC-GFP and Thy1 (surface labelling). Double-positive cells are labelled with an asterisk (* ). All images were taken at 40× magnification. Scale bar, 100 μ m. k, α -MHC-GFP + Thy1 + and α -MHC-GFP − Thy1 + cells were FACS-sorted from day-7 MGTtransduced cardiac fibroblasts and expression of representative cardiac (Myl4 and Actc1) and fibroblast (Col3a1 and Postn) markers were determined by qRT-PCR. Day-7 mock-transduced cells were included as control. Data are mean ± s.d. n = 4 samples. One-way ANOVA followed by Bonferroni correction (two-sided), * * P < 0.01, * * * P < 0.001; ns, not significant. Myl4 and Actc1 expression increased 80-100-fold and reached approximately the same level as Gapdh in α -MHC-GFP + Thy1 + cells compared to mock transduction. Expression level of the fibroblast marker Postn was maintained at a high level in GFP + Thy1 + cells. For the other fibroblast marker, Col3a1, although its relative expression in GFP + Thy1 + cells was decreased compared to mock-transduced and GFP − Thy1 + cells, but its absolute expression was still high compared to Gapdh (around 1.4-fold of Gapdh). The data strongly support the existence of cardiomyocyte-and fibroblast-marker double-positive pre-iCM and suggest that the pre-iCM state represents an intermediate cell population that is transitioning from intermediate fibroblast to iCM or that is locked between intermediate fibroblast and iCM during reprogramming. l, To determine whether iCMs may be differentiated from rare cardiac stem/progenitor cells, we plotted the expression of cardiac stem/progenitor cell markers in each of the hierarchical clustering and PCA single-cell groups using violin plots. All of these markers were nearly undetectable in fibroblasts, intermediate fibroblasts, pre-iCMs and iCMs, suggesting the direct conversion from cardiac fibroblast to iCM without going through a stem/progenitor cell stage. m, Distribution of gene expression levels in single cells. Data are mean ± s.e.m. n = 454 cells. The limit of gene detection was set to 1 based on this plot. n, Distribution of the number of genes detected in all, CCI or CCA single cells. Comparison of the distributions in CCI and CCA cells using a two-sample Kolmogorov-Smirnov test resulted in a one-sided P value of 5.248 × 10 -11 , suggesting that the number of genes in CCI is significantly smaller than in CCA. On the basis of this result, only CCI cells were used in o. o, Distribution of the number of genes detected in each CCI cell group. Analysis using a one-sided, two-sample Kolmogorov-Smirnov test (P values: 0.00521 for intermediate fibroblasts versus fibroblasts, 0.00481 for pre-iCMs versus intermediate fibroblasts and 1.104 × 10 −6 for iCMs versus pre-iCMs) suggests that the number of genes expressed decreased when the cells adopted the iCM fate. This observation demonstrates a dynamic re-patterning of transcription machinery during reprogramming and is consistent with the hierarchical clustering analysis and experimental evidence that pre-iCMs co-expressed both cardiac and fibroblast markers, further indicating that the pre-iCM state constitutes an intermediate population during iCM reprogramming. p-v, Population-based gene expression profiling of reprogramming cardiac fibroblasts at day 0, 3, 5, 7, 10 and 14. p, q, Results from PCA analysis using all genes were similar to those using the top 400 genes (r-v). p, Scree plot of the top 10 PCs. q, A 3D PCA score plot. r-v, Analyses using the top 400 PCA genes. Related to Fig. 1g , h. r, Scree plot of top 10 PCs. s, PCA score plot using PC1 and PC3. t, Hierarchical clustering identified four major gene clusters: gradually upregulated during reprogramming (red, mainly cardiac genes), downregulated in MGT-transduced compared to LacZ-transduced (blue, mainly extracellular matrix (ECM) genes) and gradually upregulated (light grey) or downregulated (dark grey) in both LacZ and MGT cells (culture or viral effects, mainly ECM and immune-response genes). The results are consistent with the expression of representative genes selected from single-cell data (Fig. 1h) , showing gradually increased expression of cardiomyocyte markers during reprogramming, first increased and then decreased expression of cell-cycle genes in both MGT and LacZ cells, and significantly lower fibroblast markers in MGT compared to LacZ cells at each time point. u, Heat map showing loading (weight) of the genes in t in PC1, 2 and 3. Upregulated (cardiac) genes are highly weighted in PC1, and the other three gene clusters are highly weighted in PC2 and PC3. The results are consistent with s and Fig. 1g . v, Gene ontology analysis of the four gene clusters in t, showing gene ontology terms and their corresponding P values (listed on the right).

Extended Data Figure 9 | Splicing re-patterning and transcriptome shift underlying shPtbp1-mediated enhancement of iCM reprogramming, and correlation of Mef2c, Gata4 and Tbx5 expression and reprogramming. a-n, Splicing analyses of day-3 reprogramming cells upon Ptbp1 silencing. Related to Fig. 3j-q . a, Number of overlapping and non-overlapping alternative splicing events identified between MGT versus LacZ and MGT and shPtbp1 versus MGT and shNT. The minimal overlap suggests that Ptbp1 knockdown caused extensive re-patterning of the splicing landscape during iCM induction. b, Number of exon-skipping events that skip (grey) or include (red) the exon more in MGT and shPtbp1 compared to MGT and shNT. c, Gene ontology analysis of alternative splicing genes between MGT and LacZ. d, e, A total of 138 alternative splicing events (83 genes) between MGT and shPtbp1 and MGT and shNT were reported by rMATS to be the most significant (P value = 0, which was actually < 1 × 10 −16 ). d, Top 10 events ranked by junction counts include four events on tropomyosin genes (Tpm1 and Tpm2). Tropomyosins are essential genes for muscle contraction and they are known to undergo extensive alternative splicing 40 . The most studied tropomyosin alternative splicing events have been mutually exclusive exons and it is interesting to find two exon-skipping events of Tpm1 as the top 2 alternative splicing events upon Ptbp1 knockdown during reprogramming. AS, alternative splicing event; A3SS, alternative 3′ splicing site; ES, exon-skipping event; IR, intron retention. e, Gene ontology analysis of the most significant alternative splicing genes. f-i, Sashimi plots for the rest of the representative alternative splicing events in the blue-labelled gene ontology terms in Fig. 3n . The event shown in Fig. 3o was for Mbnl, which is an essential splicing factor for cardiac function that switches isoforms during heart development 41 . The event shown in h was an exonskipping event in Tpm1 exon 3 (exon 2b in older literature), which was also the top event in d. This exon-3-skipped isoform of Tpm1 (Tpm1α ) is the one enriched in cardiac and striated muscle cells, regulating the assembly and functionality of actin filament for contraction 42 . j, Overlap of alternative splicing genes and differentially expressed genes between MGT and shPtbp1 versus MGT and shNT cells. k, Overlap of differentially expressed genes between MGT versus LacZ and MGT and shPtbp1 versus MGT and shNT. l, Percentage of overlapping differentially expressed genes in k, showing the same or opposite direction of changes. m-o, On the basis of the results shown in k, top gene ontology terms for differentially expressed genes between MGT and LacZ (m), overlapping differentially expressed genes (n) and differentially expressed genes (DEG) between MGT and shPtbp1 and MGT and shNT (o) are shown. p-s, Correlation between Mef2c, Gata4 and Tbx5 expression and reprogramming. Related to Fig. 4a. p Genes with correlation coefficient > 0.3 or < -0.3 with one or more of Mef2c, Gata4 and Tbx5 were selected and the intercorrelation matrix of the 17 selected splicing factors (t) and the 65 selected transcription factors (u) were calculated and plotted as a heat map. The splicing factors Mbnl1 and Rbms3 are strongly anti-correlated with expression of Mef2c, Gata4 and Tbx5, and Rbm20 is the only factor that is positively correlated with expression Mef2c, Gata4 and Tbx5 (P < 1 × 10 −7 by two-sided Spearman correlation, α = 0.05). In u, two sets of genes, A and B, were found to be strongly anti-correlated with Mef2c, Gata4 and Tbx5 expression and that were also strongly co-expressed. These genes include Id1, Id2, Id3, Tcf21 and Foxp1 (P < 1 × 10 -15 by two-sided Spearman correlation, α = 0.05) that might serve as 'secondary' key factors that further trigger the activation/inhibition of downstream cascades for successful conversion from fibroblasts to iCMs. Corresponding author(s): Li Qian
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Data exclusions
Describe any data exclusions.
Multimers and empty capture sites on the C1 plate were excluded for downstream cDNA library construction. After gene counting, each cells' % reads mapped to spikein and % reads mapped to mouse mRNA were plotted and outliers are removed. After Combat normalization, the last few outliers were removed using the default "outlier removal" function in the SinGuLAR analysis package from Fluidigm, which was based on median gene expression level in each cell.
Replication
Describe whether the experimental findings were reliably reproduced.
The number of replication plates for scRNA-seq were: five plates for M+G+Ttransduced cells (three full plates and two half plates), four plates for DsRed retroviral transduction control cells (four half plates), and two half plates for untransduced control cells. Experimental findings from the scRNA-seq data were reproducible. All other cell culture experiments were also repeated for usually three or more times. Conclusions were only made when results were consistent among replicate experiments.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
For scRNA-seq data, we intentionally mixed differently-treated samples in the sample plate (plate M4, M5, C1, and C2) for the purpose of randomization. For most cell culture experiments, at least one other postdoc repeated the experiment and verified the results. For important findings such as the role of Ptbp1 knockingdown on iCM reprogramming, all four participating postdocs have repeated the experiment and confirmed the finding.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Blinding was widely used in the study. Data collection and analysis, such as immunostaining, image counting, RNA extraction, and qRT-PCR, were frequently performed by participants other than the experiment designer. During these data collection and analysis steps, the participants were routinely blinded to group allocation.
nature research | life sciences reporting summary
June 2017
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
fastqc/0.11.4, tophat/2.1.0, samtools/0.1.19, bedtools/2.24.0, bamtools/1.0.2, bowtie2/2.2.6, pico/5.04, htseq-count/0.6.1p1, Combat, R, DESeq, DESeq2, SINGuLAR/3.5.2, Rtsne, prcomp, SLICER, LLE, rMATS/3.2.5, rMAPS/1.0.5, VGAM, FlowJo 7.6.1, Prism5
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
No unique materials were used.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species). c. Report whether the cell lines were tested for mycoplasma contamination.
All cell lines were tested negative for mycoplasma contamination.
d. If any of the cell lines used are listed in the database of commonly misidentified cell lines maintained by ICLAC, provide a scientific rationale for their use.
No commonly misidentified cell lines were used.
